Johnson & Johnson Vision Care Ireland expands Limerick facility

Johnson & Johnson Vision Care Ireland, eye health specialist and part of Johnson & Johnson MedTech, has expanded of its existing facility in Plassey, Limerick.

The €100 million investment has the potential to create 80 new jobs and will support the company’s ambition to redefine healthy sight for life for more people around the world.

The Johnson & Johnson Vision site in Limerick is one of the largest contact lens manufacturing facilities in the world. The investment will expand the facility's manufacturing capacity, with the installation of fully automated flexible manufacturing lines built with industry-leading technology. This will support the future growth of Johnson & Johnson Vision Care’s ACUVUE Astigmatism product family and deliver the company’s future new product introduction pipeline. Construction is currently underway with production expected to commence in 2024.

Taoiseach Micheál Martin TD said: “The medtech sector is a crucial part of the Irish economy, and the continued commitment shown by Johnson & Johnson Vision to do business here is most welcome. The work done at their Limerick facility has a profound impact on the lives of people all over the world, and I am delighted that this site continues to go from strength to strength.”

The Johnson & Johnson Vision site in Limerick plays a key role in the Johnson & Johnson Vision contact lens business, supporting the production of the company’s fastest-growing daily disposable lenses for global markets.

Chris Ewer, vice president, E2E supply chain leader, Johnson & Johnson Vision Care said: “Globally, at least 2.2 billion people have a vision impairment. With the growth of our manufacturing operations in Limerick and our strong supply chain network around the world, we look forward to supporting more patients and eye care professionals with the products they need where they need them. Our 25 years of experience working in Ireland is remarkable and the expansion of our site is proof of our commitment to helping more patients around the globe.”